Pharma Industry News Weekly Recap: August 11, 2023
// Biotech and Pharma Therapeutics Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window' [...]
// Biotech and Pharma Therapeutics Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window' [...]
// Biotech and Pharma Therapeutics AbbVie sends SHP2 deal back to port, following Big Pharma peer in retreating [...]
// Biotech and Pharma Therapeutics Uber Health Launches Grocery & OTC Item Delivery to Patient Homes Nationwide June [...]
// Biotech and Pharma Therapeutics Lilly's Innovative Approach in the Pursuit of Pain Relief June 5, 2023 / [...]
// Biotech and Pharma Therapeutics Atea rejects takeover bid from Concentra May 30, 2023 / Atea / Concentra [...]
// Biotech and Pharma Therapeutics Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE May [...]
The U.S. Food and Drug Administration has approved erenumab (Aimovig™, Amgen and Novartis), a first-in-class calcitonin gene-related peptide (CGRP) antagonist, [...]